Regeneron Says Covid Antibody Drug Also Effective As Preventive
The drugmaker says a single shot of its monoclonal antibody treatment reduced the chances of developing covid after exposure to the virus by 81%, which suggests it could be effective as a preventive. Regeneron is now seeking FDA approval for this.